Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids [Phase 2]

View source ↗

Summary

Phase 2 dose range finding study to assess the efficacy and safety of Tozorakimab in adults with uncontrolled asthma on medium-to-high dose inhaled corticostero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tozorakimab (tozorakimab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: RECRUITING